A phase I study of R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist given weekly in patients with advanced solid tumors
Year: 2007
Type: article
Study design: Clinical Trial
Source: Molecular Cancer Therapeutics
Institution: University of Colorado Cancer Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2512096769
